David Stamler

David Stamler

Algemeen Directeur bij ALTERITY THERAPEUTICS LIMITED

Vermogen: 689 389 $ op 31-08-2026

65 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Dr. David A. Stamler, MD, is a Chief Executive Officer, MD & Director at Alterity Therapeutics Ltd. He is on the Board of Directors at Alterity Therapeutics Ltd. Dr. Stamler was previously employed as a Vice President-Clinical Development & Therapeutic by Teva Pharmaceutical Industries Ltd., a Chief Medical Officer by Auspex Pharmaceuticals, Inc., a Chief Medical Officer & Senior Vice President by XenoPort, Inc., a Chief Scientific Officer & Head-Drug Development by Prestwick Pharmaceuticals, Inc., a Senior Global Project Leader-CNS Diseases by Fujisawa Pharmaceutical Co., Ltd., a Vice President- Clinical Research Center by Astellas Research Institute of America LLC, a Vice President-Research & Development by Fujisawa Healthcare, Inc., and a Director-Clinical Research by Abbott Laboratories.
He received his undergraduate degree from The University of Chicago and a doctorate degree from Pritzker School of Medicine.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-08-2026 1.904.863 ( 0,87% ) 689 389 $ 31-08-2026

Actieve functies van David Stamler

BedrijvenFunctieBegin
ALTERITY THERAPEUTICS LIMITED Algemeen Directeur 07-01-2021

Eerdere bekende functies van David Stamler

BedrijvenFunctieEinde
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01-01-2017
AUSPEX PHARMACEUTICALS INC Hoofd Techniek/Wetenschap/O&O 05-05-2015
XENOPORT, INC. Hoofd Techniek/Wetenschap/O&O 19-11-2010
Hoofd Techniek/Wetenschap/O&O 01-01-2008
Corporate Officer/Principal 01-01-2005
Ervaring van David Stamler in detail bekijken

Opleiding van David Stamler

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

68

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Fujisawa Healthcare, Inc.

Commercial Services

Health Technology

Consumer Services

  1. Beurs
  2. Insiders
  3. David Stamler
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU